Recently, a study suggested that FN1 promotes cellular aggregate formation conferring anoikis resistance to tumor cells (Han et al., 2021), and that pretreatment of exosomes with anti-FN1 antibodies attenuates the invasive ability of fibroblasts (Shafiq et al., 2021). Here, FN1 is linked to neoplasm.